Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-2-15
pubmed:abstractText
Telomerase adds telomeric repeats to the ends of telomeres to compensate for their progressive loss. A favorable prognosis is associated with low or no telomerase in some tumors. The authors investigated whether telomerase activity is associated with survival of patients with brain tumors. Sixty-two consecutive patients with brain tumors underwent surgery, and their surgical specimens were investigated. The patients were pathologically categorized as group I (aggressive group) and group II (non-aggressive group). Telomerase activity was examined by the telomeric repeat amplification protocol (TRAP) assay. The median time was calculated in association with overall survival and progression-free survival in each group. The significant difference was noted in telomerase activity between high-grade gliomas and lowgrade gliomas (p=0.022). Telomerase activity was significantly associated with the median overall survival and progression-free survival in all tumors of the aggressive group. On the other hand, the median overall survival in the non-aggressive group was not dependent on telomerase activity, while the median progression-free survival was. Our data suggests that telomerase is an important prognostic indicator of survival in patients with brain tumors.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-10449030, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-10491533, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-10917055, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-11107139, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-11981616, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-12825819, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-12871779, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-15162351, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-1708110, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-2342578, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-3907856, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-7605428, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-8159672, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-9020079, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-9389643, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-9419332, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-9605755, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-9750021, http://linkedlifedata.com/resource/pubmed/commentcorrection/16479078-9879692
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1011-8934
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
126-30
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Prognostic implication of telomerase activity in patients with brain tumors.
pubmed:affiliation
Department of Neurosurgery, Hanyang University College of Medicine, Seoul, Korea. kch5142@hanyang.ac.kr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't